Filing Flows › Acadia Pharmaceuticals (ACAD) › Recalls, complaints & regulation
Acadia Pharmaceuticals (ACAD): clinical trials
Acadia Pharmaceuticals (ACAD) beyond its filings: 5 active clinical trials.
Acadia Pharmaceuticals' latest quarter
Acadia Pharmaceuticals, Q3 2026: revenue $342M (+23% year over year), operating margin 21.0%, net earnings $53.5M, operating cash flow $11.5M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Acadia Pharmaceuticals have?
5 active studies on ClinicalTrials.gov, 3 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.